| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/25/2009 | EP2037953A2 Methods of treating acute blood loss anemia with a cross-linked hemoglobin blood substitute |
| 03/25/2009 | EP2037950A2 Further medical uses of antisecretory protein |
| 03/25/2009 | EP2037922A2 Prolyl hydroxylase inhibitors |
| 03/25/2009 | EP2000540A9 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer |
| 03/25/2009 | EP1945266A4 Methods of modulating apoptosis and platelet production using variants of cytochrome c |
| 03/25/2009 | EP1565206B1 Novel use of erythropoietin in heart diseases |
| 03/25/2009 | EP1460999B1 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 03/25/2009 | EP1319183B1 Methods and products related to low molecular weight heparin |
| 03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/25/2009 | CN101392218A Nutrient health wine brewed by natural honey and Chinese herbal medicine and preparation method thereof |
| 03/25/2009 | CN101392002A Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis |
| 03/25/2009 | CN101391100A Use of recombined human source thioredoxin in preparing medicine for treating endotoxemia |
| 03/25/2009 | CN101391056A Medicine for treating aplastic anemia |
| 03/25/2009 | CN101391014A Traditional Chinese medicine composition for treating blood disease and preparation method thereof |
| 03/25/2009 | CN101390986A Traditional Chinese medicine composition for cerebral thrombus and preparation method thereof |
| 03/25/2009 | CN101390887A Medicine composition of Panax notoginseng saponins |
| 03/25/2009 | CN101390878A Preparation method of natural pyrolusite emergency haemostatic for external use |
| 03/25/2009 | CN101390877A Preparation method of natural montmorillonite emergency haemostatic for external use |
| 03/25/2009 | CN101390876A Preparation method of natural montmorillonite emergency haemostatic for external use |
| 03/25/2009 | CN101390856A Solid preparation of clopidogrel and preparation method thereof |
| 03/25/2009 | CN101390839A Policosanol drop pill and preparation method thereof |
| 03/25/2009 | CN100471842C Quinolone derivative or its salt |
| 03/25/2009 | CN100471518C Chinese medicinal powder with gall, giant knotweed, hyacinth bletilla and bornel |
| 03/25/2009 | CN100471498C Pharmaceutical composition of ligustrazine and carthamin yellow |
| 03/25/2009 | CN100471489C Soft capsule containing Lamiophlomis rotata Kudo. root extract |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507540 determining the presence of catalytic antibodies capable of degrading antihemophilic factors in mammals; analyzing the cleavage sites in the antihemophilic factors; biocatalysts; drugs |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507412 for drug screening; kits for collagen and/or platelet-collagen interaction; for treatment of thrombotic and cardiovascular events and disorders |
| 03/24/2009 | CA2450690C Improved chelator conjugates |
| 03/24/2009 | CA2087271C Superior thrombomodulin analogs for pharmaceutical use |
| 03/19/2009 | WO2009033774A2 Use of a laminin nonapeptide as a therapeutic agent |
| 03/19/2009 | WO2009033773A2 Use endothelin 2, alone or combined with a nonapeptide, a peptide as a therapeutic agent |
| 03/19/2009 | WO2009033396A1 Dithiolopyrrolone compounds, the preparation and the use thereof |
| 03/19/2009 | WO2009012438A3 Application of polymeric materials to screens to facilitate hemostasis and wound healing |
| 03/19/2009 | WO2008157593A3 Protein c for use in maintaining hemostasis |
| 03/19/2009 | WO2008155069A3 Substituted oxazolidinones and use thereof |
| 03/19/2009 | WO2008063157A3 A nanoparticle-based anticoagulant |
| 03/19/2009 | US20090076256 Degradation-resistant mononucleoside phosphate compounds |
| 03/19/2009 | US20090075992 Pteridine Derivatives as Nitric Oxide Synthase Activators |
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |
| 03/19/2009 | US20090075914 Deuterium-enriched odiparcil |
| 03/19/2009 | US20090075913 Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent |
| 03/19/2009 | US20090075910 Deuterium-enriched fondaparinux |
| 03/19/2009 | US20090075903 increases differentiation of high proliferative potential-stem and progenitor cells, colony forming cells-granulocyte, erythroid, macrophage, megakaryocyte cells, granulocyte-macrophage-colony forming cells, megakaryocyte-colony forming cells, T-lymphocytes; refractory anemia |
| 03/19/2009 | US20090075899 Inhibiting collagen-induced platelet aggregation and activation with peptide variants |
| 03/19/2009 | US20090075895 Stabilised Solid Composition of Modified Factor VII |
| 03/19/2009 | US20090075884 Human il-17f and other il-17f-related proteins and methods related thereto |
| 03/19/2009 | US20090075875 Protection against lung fibrosis by up-regulating the function or expression of caveolin-1 |
| 03/19/2009 | US20090075303 Allo and Auto-Reactive T-Cell Epitopes |
| 03/19/2009 | US20090074870 Alteration of cell membrane for new functions |
| 03/19/2009 | US20090074859 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 03/19/2009 | US20090074844 Trenadermal absorption preparation |
| 03/19/2009 | US20090074830 Anti-angiogenic compositions and methods of use |
| 03/19/2009 | US20090074829 Novel Heparin Alternative Material and Method for Producing the Same |
| 03/19/2009 | US20090074744 Use of collagenase to facilitate guide wire crossing in total arterial occlusions |
| 03/19/2009 | US20090074737 Compositions and methods for prolonging survival of platelets |
| 03/19/2009 | DE102007045038A1 Arzneimittel zur Behandlung oder Prävention von Proteinurie Drugs for the treatment or prevention of proteinuria |
| 03/18/2009 | EP2036926A2 Single-chain, multiple antigen forming molecule, its manufacture and use |
| 03/18/2009 | EP2036891A2 Isoquinoline inhibitors of P38 |
| 03/18/2009 | EP2035092A2 Use of kw-3902 for achieving diuresis in patients with congestive heart failure and acute fluid overload |
| 03/18/2009 | EP2035027A1 Therapeutic uses of tomato extracts |
| 03/18/2009 | EP2035000A1 Hif hydroxylase inhibitors for treatment of anemia of cancer |
| 03/18/2009 | EP1517918B1 Peptides having affinity for a phospholipid and uses |
| 03/18/2009 | EP1513806B1 Sulphonic acid salts of mandelic acid derivatives |
| 03/18/2009 | EP1495763B1 Therapeutic cream for dermatitis |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | CN101389613A Macrocyclic factor viia inhibitors useful as anticoagulants |
| 03/18/2009 | CN101389332A Preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemia reperfusion in stroke |
| 03/18/2009 | CN101386848A MiRNA with cell corpuscule as vector and preparation research approach thereof and application |
| 03/18/2009 | CN101386651A Expression and export of angiostatin and endostatin as immunofusis |
| 03/18/2009 | CN101386635A Method for preparing photo-stable methylamino avermectin |
| 03/18/2009 | CN101386596A 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
| 03/18/2009 | CN101385808A Quality control method of Zhubai tranquilizing pill |
| 03/18/2009 | CN101385792A Liquor for treating disease and preparation method thereof |
| 03/18/2009 | CN101385789A Medicine for increasing leucocyte and preparation method thereof |
| 03/18/2009 | CN101385767A Watermelon seeds oil soft capsules and preparation method thereof |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/18/2009 | CN100469371C Manufacturing technique for gingko leaf extracts |
| 03/18/2009 | CN100469368C Use of adatanserin for treating neurogenerative disorders |
| 03/17/2009 | US7504500 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 03/17/2009 | US7504417 Substituted benzene derivatives or salts thereof |
| 03/17/2009 | US7504407 2-substituted-4-(imidazolyl or pyrazolyl alkyl)amino-6-phenyl-pyrrolo[2,3-D]pyrimidines; Adenosine receptor inhibitors; asthma, bronchodilators, vision defects, antiischemic and antiinflammatory agents |
| 03/17/2009 | US7504113 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 03/17/2009 | US7503913 Methods and compositions for use in perfusion applications |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/17/2009 | CA2359116C Substituted porphyrins |
| 03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 03/17/2009 | CA2337849C Piperazinone derivatives and applications thereof |
| 03/12/2009 | WO2009032884A1 Wound healing with zeolite-based hemostatic devices |
| 03/12/2009 | WO2009032538A1 Method of preventing nephrocalcinosis |
| 03/12/2009 | WO2009032249A1 Soluble guanylate cyclase activators |
| 03/12/2009 | WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN |
| 03/12/2009 | WO2009030866A2 Method for purifying the factor viii and the von willebrand factor |
| 03/12/2009 | WO2009002229A3 New anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution |
| 03/12/2009 | WO2009002228A3 New thrombin function compounds and pharmaceutical compositions based on them |
| 03/12/2009 | WO2008157304A3 Stabilized thrombin compositions |
| 03/12/2009 | WO2008142267A3 Process for extracting coumarins |
| 03/12/2009 | WO2008117179A3 Polynucleotides and polypeptides of human factor vii gene, snps |
| 03/12/2009 | WO2008079836A4 Macrocyclic factor viia inhibitors useful as anticoagulants |